drugset / Trial / NCT06918808
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a double-blind, randomized, placebo-controlled, sequential cohort, ascending dose clinical trial to evaluate the safety and determine the efficacy of ascending doses of DB-3Q for the treatment of Perianal Fistulizing Crohn's Disease.
Timeline
- Start
- 2025-05-19
- Primary completion
- 2027-07-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DB-3Q | Other / unclassified | 15 ml | Other |
| Subject | DB-3Q | Other / unclassified | 30 ml | Other |